Irvine, California, March 25, 2026

Recent coverage by Renal & Urology News highlights emerging data on bladder cancer detection following hematuria which was presented at the European Association of Urology (EAU) Congress. The presentation by Promis Diagnostics can be found below for download.

The article includes findings on EarlyTect BCD Plus, demonstrating strong diagnostic performance, including high sensitivity for clinically significant disease and balanced specifically across hematuria population.

Read more about the article here: https://www.renalandurologynews.com/reports/bladder-cancer-detection-hematuria-progress-mortality-treatment/